DeLuca Richard R.
SEC CIK 1421339 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck & Co. | EVP, Pres, Merck Animal Heallth | 110.2K | — | $63.30M | 21 | 2021-10-29 | 2026-08-10 |
Most active insiders at MRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zachary Jennifer | EVP, GC | — | $25.20M |
| 2 | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | — | $11.29M |
| 3 | Guindo Chirfi | EVP, Access, Policy, Comms | — | $8.15M |
| 4 | Williams David Michael | EVP, Chief Info, Digital Off | — | $8.13M |
| 5 | Davis Robert M | COB, CEO, Pres, Dir | — | $5.60M |
| 6 | Litchfield Caroline | EVP, CFO | — | $5.02M |
| 7 | Li Dean Y | Pres, Executive VP, MRL | — | $2.99M |
| 8 | Maraldo David R. | EVP, Pres. MMD | — | $2.41M |
| 9 | Oosthuizen Johannes Jacobus | Pres, U.S. Market | — | $1.83M |
| 10 | Smart Dalton E. III | SVP Fin. - Gbl Ctrl | — | $766.0K |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-12 16:10 | 2026-08-10+ | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale | $131.12 | -45.3K | 110.2K | -29% | -$5.94M |
| M | 2026-08-10 16:28 | 2026-08-06 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale | $130.38 | -6,050 | 155.5K | -4% | -$788.8K |
| D | 2026-05-01 18:20 | 2026-04-29 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $110.03 | +2,518 | 162.8K | +2% | +$277.1K |
| D | 2026-05-01 18:20 | 2026-04-29 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | F - Tax | $110.03 | -1,241 | 161.5K | -0.8% | -$136.5K |
| 2026-02-06 | 2026-02-06 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale | $120.92 | -37.7K | 160.2K | -19% | -$4.56M | |
| 2026-01-28 | 2026-01-26 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | A - Grant | $107.40 | +12.3K | 197.9K | +7% | +$1.32M | |
| 2025-01-29 | 2025-01-27 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | A - Grant | $97.94 | +25.4K | 179.0K | +17% | +$2.49M | |
| D | 2024-05-06 | 2024-05-04 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $127.51 | +27.1K | 163.7K | +20% | +$3.46M |
| D | 2024-05-06 | 2024-05-04 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | F - Tax | $127.51 | -13.4K | 150.4K | -8% | -$1.70M |
| 2024-01-24 | 2024-01-22 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | A - Grant | $119.43 | +23.3K | 135.8K | +21% | +$2.78M | |
| 2023-11-09 | 2023-11-08 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale | $105.03 | -43.8K | 111.8K | -28% | -$4.60M | |
| DM | 2023-05-02 | 2023-04-28+ | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $58.86 | +141.6K | 229.9K | +160% | +$8.33M |
| DM | 2023-05-02 | 2023-04-28+ | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale+OE | $115.55 | -141.6K | 154.5K | -48% | -$16.36M |
| 2023-01-25 | 2023-01-23 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | A - Grant | $109.88 | +15.6K | 153.5K | +11% | +$1.72M | |
| D | 2022-11-01 | 2022-10-28 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale+OE | $100.26 | -164.6K | 137.0K | -55% | -$16.50M |
| DM | 2022-11-01 | 2022-10-28 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $0.00 | +164.6K | 196.5K | +514% | $0 |
| 2022-02-28 | 2022-02-24 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | A - Grant | $73.51 | +16.0K | 133.9K | +14% | +$1.17M | |
| D | 2021-11-05 | 2021-11-04 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $0.00 | +29.8K | 146.7K | +25% | $0 |
| D | 2021-11-05 | 2021-11-04 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale+OE | $90.40 | -29.8K | 116.9K | -20% | -$2.69M |
| DM | 2021-11-02 | 2021-10-29 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $0.00 | +135.4K | 190.0K | +248% | $0 |
| D | 2021-11-02 | 2021-10-29 | MRK | Merck & Co. | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale+OE | $87.56 | -135.4K | 116.9K | -54% | -$11.86M |
Purchase Sale Sale after option exercise All abbreviations